Cargando…
1348. A Novel Host-Protein Signature Comprising TRAIL, IP-10 and CRP Differentiates Bacterial from Viral Infection in COPD Patients with Suspected Lower Respiratory Tract Infection
BACKGROUND: Identifying infectious etiology is often challenging, yet essential for patient management, including antibiotic use. Studies have shown that a host signature comprising TNF-related apoptosis induced ligand (TRAIL), interferon gamma induced protein-10 (IP-10) and C-reactive protein (CRP)...
Autores principales: | Halabi, Salim, Shiber, Shachaf, Stein, Michal, Paz, Meital, Gottlieb, Tanya, Barash, Eran, Navon, Roy, Moscoviz, Einat, Ber, Tahel Ilan, Shani, Liran, Petersiel, Neta, Boico, Olga, Grupper, Mordechai, Simon, Einav, Kirshner, Dani, Avni, Noa, Haber, Daniel, Maor, Yasmin, Guetta, Claire S, Lishtzinsky, Ynon, Yanai, Shirly, Drescher, Michael, Oved, Kfir, Eden, Eran, Neuberger, Ami, Paul, Mical |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8644870/ http://dx.doi.org/10.1093/ofid/ofab466.1540 |
Ejemplares similares
-
2224. Reducing Antibiotic Overuse in Adult Lower Respiratory Tract Infections Using Novel Host–Response-Based Diagnostics
por: Shani, Liran, et al.
Publicado: (2019) -
1213. A TRAIL/IP-10/CRP Signature Distinguishes between Viral and Bacterial Infection in Chronic Obstructive Pulmonary Disease Patients
por: Paz, Meital, et al.
Publicado: (2020) -
426. Use of Real Time IP-10 Measurements to Identify and Monitor the Dysregulated Immune Response in COVID-19 Patients
por: Lev, Shaul, et al.
Publicado: (2020) -
Differential Serum and Urine CRP, IP-10, and TRAIL Levels in Pediatric Urinary Tract Infection
por: Ashkenazi-Hoffnung, Liat, et al.
Publicado: (2021) -
Observational cohort study of IP-10’s potential as a biomarker to aid in inflammation regulation within a clinical decision support protocol for patients with severe COVID-19
por: Lev, Shaul, et al.
Publicado: (2021)